Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 84

1.

Guidance on 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy from the Experience of a Single Nuclear Medicine Division.

Abbott A, Sakellis CG, Andersen E, Kuzuhara Y, Gilbert L, Boyle K, Kulke MH, Chan JA, Jacene HA, Van den Abbeele AD.

J Nucl Med Technol. 2018 Sep;46(3):237-244. doi: 10.2967/jnmt.118.209148. Epub 2018 Aug 3.

2.

Development and validation of a new MRI simulation technique that can reliably estimate optimal in vivo scanning parameters in a glioblastoma murine model.

Protti A, Jones KL, Bonal DM, Qin L, Politi LS, Kravets S, Nguyen QD, Van den Abbeele AD.

PLoS One. 2018 Jul 23;13(7):e0200611. doi: 10.1371/journal.pone.0200611. eCollection 2018.

3.

Effects of hyperglycemia on fluorine-18-fluorodeoxyglucose biodistribution in a large oncology clinical practice.

Rosica D, Cheng SC, Hudson M, Sakellis C, Van den Abbeele AD, Kim CK, Jacene HA.

Nucl Med Commun. 2018 May;39(5):417-422. doi: 10.1097/MNM.0000000000000829.

PMID:
29629997
4.

LesionTracker: Extensible Open-Source Zero-Footprint Web Viewer for Cancer Imaging Research and Clinical Trials.

Urban T, Ziegler E, Lewis R, Hafey C, Sadow C, Van den Abbeele AD, Harris GJ.

Cancer Res. 2017 Nov 1;77(21):e119-e122. doi: 10.1158/0008-5472.CAN-17-0334.

5.

Surveillance Imaging in Patients With Endometrial Cancer in First Remission.

Alabed YZ, Cheng SC, Mudge C, Sakellis C, Van den Abbeele AD, Campos SM, Jacene HA.

Curr Probl Diagn Radiol. 2018 Sep;47(5):311-316. doi: 10.1067/j.cpradiol.2017.08.003. Epub 2017 Aug 24.

PMID:
28917433
6.

Immune Modulation Therapy and Imaging: Workshop Report.

Shields AF, Jacobs PM, Sznol M, Graham MM, Germain RN, Lum LG, Jaffee EM, de Vries EGE, Nimmagadda S, Van den Abbeele AD, Leung DK, Wu AM, Sharon E, Shankar LK.

J Nucl Med. 2018 Mar;59(3):410-417. doi: 10.2967/jnumed.117.195610. Epub 2017 Aug 17.

7.

Cancer Imaging Fellowship Training: Utility and Added Value in the Modern Era.

Krajewski KM, Howard SA, Shinagare AB, Van den Abbeele AD, Fennessy FM.

J Am Coll Radiol. 2017 Oct;14(10):1345-1348. doi: 10.1016/j.jacr.2017.06.005. Epub 2017 Jul 8. No abstract available.

PMID:
28697959
8.

Ovarian Cancer: An Evidence-Based, Easy-to-Use Prediction Rule to Optimize the Use of Follow-up Chest CT.

Shinagare AB, Suh CH, Kim KW, Somarouthu B, Van den Abbeele AD, Ramaiya NH.

J Am Coll Radiol. 2017 Apr;14(4):499-508. doi: 10.1016/j.jacr.2016.08.010. Epub 2016 Oct 6.

PMID:
27720583
9.

Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma.

O'Neill AF, Qin L, Wen PY, de Groot JF, Van den Abbeele AD, Yap JT.

J Neurooncol. 2016 Dec;130(3):495-503. Epub 2016 Aug 30.

PMID:
27576699
10.

Patterns and Prognostic Importance of Hepatic Involvement in Patients with Serous Ovarian Cancer: A Single-Institution Experience with 244 Patients.

O'Neill AC, Somarouthu B, Tirumani SH, Braschi-Amirfarzan M, Van den Abbeele AD, Ramaiya NH, Shinagare AB.

Radiology. 2017 Jan;282(1):160-170. doi: 10.1148/radiol.2016152595. Epub 2016 Aug 1.

PMID:
27479640
11.

Cancer Imaging at the Crossroads of Precision Medicine: Perspective From an Academic Imaging Department in a Comprehensive Cancer Center.

Van den Abbeele AD, Krajewski KM, Tirumani SH, Fennessy FM, DiPiro PJ, Nguyen QD, Harris GJ, Jacene HA, Lefever G, Ramaiya NH.

J Am Coll Radiol. 2016 Apr;13(4):365-71. doi: 10.1016/j.jacr.2015.11.002. Epub 2016 Jan 14.

PMID:
26774886
12.

Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model.

Reardon DA, Gokhale PC, Klein SR, Ligon KL, Rodig SJ, Ramkissoon SH, Jones KL, Conway AS, Liao X, Zhou J, Wen PY, Van Den Abbeele AD, Hodi FS, Qin L, Kohl NE, Sharpe AH, Dranoff G, Freeman GJ.

Cancer Immunol Res. 2016 Feb;4(2):124-35. doi: 10.1158/2326-6066.CIR-15-0151. Epub 2015 Nov 6.

13.

Pancreatitis Secondary to Anti-Programmed Death Receptor 1 Immunotherapy Diagnosed by FDG PET/CT.

Alabed YZ, Aghayev A, Sakellis C, Van den Abbeele AD.

Clin Nucl Med. 2015 Nov;40(11):e528-9. doi: 10.1097/RLU.0000000000000940.

PMID:
26284765
14.

Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma.

Buchbinder EI, Sosman JA, Lawrence DP, McDermott DF, Ramaiya NH, Van den Abbeele AD, Linette GP, Giobbie-Hurder A, Hodi FS.

Cancer. 2015 Nov 15;121(22):4007-15. doi: 10.1002/cncr.29622. Epub 2015 Aug 11.

15.

Role of FDG-PET/CT in Extramedullary Multiple Myeloma: Correlation of FDG-PET/CT Findings With Clinical Outcome.

Tirumani SH, Sakellis C, Jacene H, Shinagare AB, Munshi NC, Ramaiya NH, Van den Abbeele AD.

Clin Nucl Med. 2016 Jan;41(1):e7-13. doi: 10.1097/RLU.0000000000000902.

PMID:
26252323
16.

Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003).

Lin NU, Guo H, Yap JT, Mayer IA, Falkson CI, Hobday TJ, Dees EC, Richardson AL, Nanda R, Rimawi MF, Ryabin N, Najita JS, Barry WT, Arteaga CL, Wolff AC, Krop IE, Winer EP, Van den Abbeele AD.

J Clin Oncol. 2015 Aug 20;33(24):2623-31. doi: 10.1200/JCO.2014.60.0353. Epub 2015 Jul 13.

17.

Cancer Imaging Training in the 21st Century: An Overview of Where We Are, and Where We Need To Be.

Howard SA, Krajewski KM, Weissman BN, Seltzer SE, Ramaiya NH, Van den Abbeele AD.

J Am Coll Radiol. 2015 Jul;12(7):714-20. doi: 10.1016/j.jacr.2015.03.044.

PMID:
26143565
18.

[(18)F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of LAPC4-CR Castration-Resistant Prostate Cancer Xenograft Model in Soft Tissue Compartments.

McCall KC, Cheng SC, Huang Y, Kohl NE, Tupper T, Van den Abbeele AD, Zukotynski KA, Sweeney CJ.

Transl Oncol. 2015 Jun;8(3):147-53. doi: 10.1016/j.tranon.2015.03.004.

19.

Advanced High-Grade Serous Ovarian Cancer: Frequency and Timing of Thoracic Metastases and the Implications for Chest Imaging Follow-up.

Shinagare AB, O'Neill AC, Cheng S, Somarouthu B, Tirumani SH, Nishino M, Van den Abbeele AD, Ramaiya NH.

Radiology. 2015 Dec;277(3):733-40. doi: 10.1148/radiol.2015142467. Epub 2015 Jun 5.

PMID:
26053310
20.

Cancer immunotherapy: imaging assessment of novel treatment response patterns and immune-related adverse events.

Kwak JJ, Tirumani SH, Van den Abbeele AD, Koo PJ, Jacene HA.

Radiographics. 2015 Mar-Apr;35(2):424-37. doi: 10.1148/rg.352140121.

PMID:
25763727

Supplemental Content

Loading ...
Support Center